Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous T cell lymphoma.

R M Knobler, R L Edelson

    The Medical Clinics of North America
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Cutaneous T cell lymphoma (CTCL) is a common adult cancer affecting T cells that infiltrate the skin. Understanding CTCL biology is key to developing better treatments for this prevalent malignancy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Induction of anti-tumor CD8 T cell responses by experimental ECP-induced human dendritic antigen presenting cells.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2016
    Same author

    Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy.

    Clinical and experimental immunology·2013
    Same author

    The balance between immunity and tolerance: the role of Langerhans cells.

    Cellular and molecular life sciences : CMLS·2008
    Same author

    Cutaneous T cell lymphoma: translating immunobiology into therapeutic opportunities.

    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2008
    Same author

    Assessing the potential role of photopheresis in hematopoietic stem cell transplant.

    Bone marrow transplantation·2006
    Same author

    Regional anticoagulation with acid citrate dextrose-A for extracorporeal photoimmunochemotherapy.

    Vox sanguinis·2002
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Oncology
    • Dermatology
    • Immunology

    Background:

    • Cutaneous T cell lymphoma (CTCL) is a cancer of helper T cells.
    • These malignant cells characteristically infiltrate the skin.
    • CTCL is the most common lymphoma diagnosed in adults.

    Purpose of the Study:

    • To summarize the current understanding of CTCL.
    • To highlight the increasing incidence of CTCL.
    • To emphasize the need for novel therapeutic strategies.

    Main Methods:

    • Literature review of CTCL biology and epidemiology.
    • Analysis of incidence data compared to other lymphomas.
    • Synthesis of current knowledge on T cell malignancy.

    Main Results:

    Related Experiment Videos

    • CTCL incidence may surpass that of Hodgkin's disease.
    • CTCL represents a significant proportion of adult lymphoma cases.
    • The disease primarily involves skin-homing T lymphocytes.

    Conclusions:

    • Further research into malignant T cell biology is crucial.
    • Advances in understanding CTCL pathogenesis will drive treatment innovation.
    • More effective therapies are anticipated based on biological insights.